STXS AMEX
Stereotaxis, Inc.
1W: -9.2%
1M: -14.5%
3M: -37.6%
YTD: -49.1%
1Y: -62.4%
3Y: -26.2%
5Y: -79.5%
$1.18
-0.02 (-1.67%)
Weekly Expected Move ±5.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$115.6M
52W Range1.18-3.59
Volume343,737
Avg Volume726,392
Beta1.42
Dividend—
Analyst Ratings
Company Info
CEODavid L. Fischel
Employees131
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2004-08-12
Websitestereotaxis.com
710 North Tucker Boulevard
St. Louis, MO 63101
US
St. Louis, MO 63101
US
314 678 6100
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Latest News
Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition?
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
Stereotaxis expects recurring revenue to reach $8M in Q4 2026 as MAGiC adoption remains supply constrained
Here are the major earnings before the open Wednesday
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Curet Myriam | A-Award | 43,103 | — | 2026-07-01 |
| Fischel Nathan | A-Award | 43,103 | — | 2026-07-01 |
| Menawat Arun Swarup | A-Award | 43,103 | — | 2026-07-01 |
| SHAMIR NACHUM | A-Award | 43,103 | — | 2026-07-01 |
| Benfer David | A-Award | 43,103 | — | 2026-07-01 |